Atlas Trials

The Use of Exosomes for the Treatment of Acute Respiratory Distress Syndrome or Novel Coronavirus Pneumonia Caused by COVID-19

Clinical trial NCT04798716 · UNKNOWN

Trial details

NCT number
NCT04798716
Sponsor
AVEM HealthCare
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Covid19Novel Coronavirus PneumoniaAcute Respiratory Distress Syndrome
Start date
2023-09-01
Primary completion
2024-09-01
Enrollment
55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.